openPR Logo
Press release

Sickle Cell Anaemia Testing Market Size, Share, Growth, Forecast and Outlook (2024-2031)

04-04-2024 12:30 PM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

DataM Intelligence

DataM Intelligence

Global Sickle Cell Anemia Testing Market Projected to Surge, Reaching US$ YY Million by 2031

The latest report on the global Sickle Cell Anemia Testing Market indicates a significant growth trajectory, with a valuation of US$ YY million achieved in 2023 and an anticipated surge to US$ YY million by 2031. The market is poised to expand at a commendable Compound Annual Growth Rate (CAGR) of YY% during the forecast period spanning from 2024 to 2031.

Sickle cell disease diagnosis relies on detecting abnormal hemoglobin in the blood, particularly crescent or sickle-shaped red blood cells (RBCs). Common testing methods include Hemoglobin S Solubility Test, Sodium Metabisulfite Test, Hemoglobinopathy (Hb) Evaluation, Genetic Testing (DNA analysis), and DNA Sequencing.

To know more Insights Download Sample: https://www.datamintelligence.com/download-sample/sickle-cell-anaemia-testing-market

Market Dynamics: Drivers & Restraints

The rise in sickle cell anemia cases globally is a primary driver propelling market growth. Sickle cell tests play a crucial role in diagnosing the disease and identifying individuals with the sickle cell trait. According to CDC reports, nearly 100,000 Americans are affected by sickle cell disease, with 1 in 365 African-Americans born with the condition annually. The disease also impacts approximately 1 in 16,300 Hispanic-American births. Moreover, in Africa, over 200,000 cases of sickle-cell anemia are reported each year among 300,000 infants born with major hemoglobin disorders.

However, the high cost of advanced testing techniques like Next-generation sequencing (NGS) and DNA microarrays poses a significant restraint to market growth, particularly in resource-constrained settings.

Market Segment Analysis

The market segmentation based on strip type, diabetes type, end-user, and region reveals the dominance of the kits segment, accounting for 54.2% of the market share. Sickle cell anemia kits offer point-of-care testing convenience, particularly suitable for clinics, hospitals, or home use. For instance, the introduction of Mylab Discovery Solutions' PathoCatch Sickle Cell Rapid Test in June 2023 underscores the market's emphasis on swift and accurate diagnosis.

Geographical Analysis

North America is poised to occupy a significant share of the global sickle cell anemia testing market. This dominance is attributed to the region's increasing disease prevalence, advancements in product offerings, and robust government support for research and development initiatives. Screening programs across US and Canadian states ensure early detection, with the introduction of rapid point-of-care tests enhancing accessibility and convenience.

Competitive Landscape

Key players dominating the market include B. Braun Medical Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Terumo Europe NV, Becton and Dickinson Company, Zenroxmed Healthcare, Shenzhen Hawk Medical Instrument Co., Ltd (Hawkmed), Baxter, ICU Medical Inc., Micrel Medical Devices SA, and QuadMed, Inc., among others.

Related Reports:

Allergy Diagnostics Market : https://www.datamintelligence.com/research-report/allergy-diagnostics-market
Fetal Monitors Market : https://www.datamintelligence.com/research-report/fetal-monitors-market
Renal Biomarkers Market : https://www.datamintelligence.com/research-report/renal-biomarkers-market
Companion Diagnostics Market : https://www.datamintelligence.com/research-report/companion-diagnostics-market
Molecular Diagnostics MarketL: https://www.datamintelligence.com/research-report/molecular-diagnostics-market
Cardiac Biomarkers Market : https://www.datamintelligence.com/research-report/cardiac-biomarkers-market

Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sickle Cell Anaemia Testing Market Size, Share, Growth, Forecast and Outlook (2024-2031) here

News-ID: 3452015 • Views:

More Releases from DataM Intelligence 4Market Research

United States Tobacco Testing Market Set for Strong Growth Amid Rising Health Regulations and Safety Standards 2025 | Top key players - Labstat International Inc., Essentra Scientific Services, Cerulean
United States Tobacco Testing Market Set for Strong Growth Amid Rising Health Re …
Market Overview: The Tobacco Testing Market is estimated to reach at a CAGR of 4% during the forecast period 2024-2031. The Tobacco Testing Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Tobacco Testing market report is an essential resource for market
United States Refractory Metals Market Set for Strong Growth Driven by High-Temperature Applications & Industrial Demand 2025 | Top key players - Terubacher Industrie AG, Rember Corporation, Codelco.
United States Refractory Metals Market Set for Strong Growth Driven by High-Temp …
Market Overview: The Refractory Metals Market is growing at a CAGR of 1.8% during the forecast period 2024-2031. The Refractory Metals Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Refractory Metals market report is an essential resource for market participants who
United States Alternative Proteins Market Set for Explosive Growth: Driving Sustainable Food Innovation 2025 | Major key players - Koninklijke DSM N.V, Kerry Group, DuPont.
United States Alternative Proteins Market Set for Explosive Growth: Driving Sust …
Market Size and Growth: The Global Alternative Proteins Market Size was valued at US$ 25.7 Billion in 2022 and is expected to reach USD 81.9 Billion by 2031, exhibiting a CAGR of 15.6% during the forecast period (2025-2032) The Alternative Proteins Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market
United States Meat Alternatives Market Surges as Consumers Embrace Plant-Based & Sustainable Protein Choices 2025 | Top key players - Vbites, MGP Ingredients, Monde Nissin Corporation.
United States Meat Alternatives Market Surges as Consumers Embrace Plant-Based & …
Market Size and Growth: The Global Meat Alternatives Market size value was USD 9.6 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 20.8 billion by 2031. The market is growing at a CAGR of 10.2% during the forecast period 2024-2031. The Meat Alternatives Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth

All 5 Releases


More Releases for Sickle

Sickle Cell Disease Treatment Market - Improving Quality of Life: Pioneering Sic …
Newark, New Castle, USA: The "Sickle Cell Disease Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Sickle Cell Disease Treatment Market: https://www.growthplusreports.com/report/sickle-cell-disease-treatment-market/7808 This latest report researches the
Sickle Cell Disease Treatment Market - Breaking the Chains of Sickle Cell: Pione …
Newark, New Castle, USA - new report, titled Sickle Cell Disease Treatment Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Sickle Cell Disease Treatment market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Sickle Cell Disease Treatment market. The report offers
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The sickle cell disease treatment market is a segment of the broader pharmaceutical industry that is focused on developing treatments for sickle cell disease, a genetic disorder that affects the red blood cells. In 2022, the sickle cell disease treatment market is expected to continue to grow, driven by the increasing prevalence of the disease and the development of new treatments. The market is expected to be worth billions of
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The sickle cell disease treatment market refers to the segment of the healthcare industry that produces and markets treatments for sickle cell disease (SCD), a genetic disorder that affects the production of hemoglobin in red blood cells. SCD can cause various complications, including pain, infections, and organ damage, and there is currently no cure for the disease. However, various treatments are available that can help manage the symptoms and improve
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The sickle cell disease treatment market refers to the segment of the pharmaceuticals industry that deals with the production and sales of treatments for sickle cell disease. Sickle cell disease is a genetic blood disorder that causes red blood cells to become misshapen and form a sickle shape. This can lead to a range of complications, including anemia, chronic pain, and increased risk of infections. The market for sickle cell disease
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The Sickle Cell Disease Treatment Market is an emerging segment in the healthcare industry. This debilitating disorder affects millions of people around the world, with no known cure available. However, recent advances in research have improved the treatment options for those suffering from sickle cell disease. The Sickle Cell Disease Treatment Market is expected to experience significant growth over the coming years as treatments become more effective and accessible. Several